日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Constructing flexible sub-nanometer ferroelectric catalyst to overcome heterocatalytic kinetic barriers for enhanced catalytic and immuno-therapy.

构建柔性亚纳米铁电催化剂，克服异质催化动力学障碍，以增强催化和免疫治疗。

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-67097-6
Zhang Rui, Yao Yuanfei, Yang Lu, Zhao Xudong, Tian Boshi, Yang Dan, Yang Piaoping
免疫/内分泌
发表日期：2025
文献求助 收藏

PGLYRP2 drives hepatocyte-intrinsic innate immunity by trapping and clearing hepatitis B virus.

PGLYRP2 通过捕获和清除乙型肝炎病毒来驱动肝细胞固有的先天免疫

期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI188083
Li Ying, Ma Huihui, Zhang Yongjian, He Tinghui, Li Binyang, Ren Haoran, Feng Jia, Sheng Jie, Li Kai, Qian Yu, Wang Yunfeng, Zhao Haoran, He Jie, Li Huicheng, Wu Hongjin, Yao Yuanfei, Shi Ming
细胞生物学
肝炎
炎症
发表日期：2025
文献求助 收藏

VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated macrophage

VDR通过激活CCL20介导的肿瘤相关巨噬细胞M2极化，在体内促进胰腺癌的进展。

期刊:Cell Communication and Signaling
影响因子:8.9
doi:10.1186/s12964-024-01578-x
Li, Hengzhen; Ruan, Yuli; Liu, Chao; Fan, Xiaona; Yao, Yuanfei; Dai, Yisheng; Song, Yushuai; Jiang, Dan; Sun, Ning; Jiao, Guangtao; Chen, Zhuo; Fan, Shiheng; Meng, Fanfei; Yang, Huike; Zhang, Yanqiao; Li, Zhiwei
巨噬细胞
肿瘤
肿瘤免疫
细胞生物学
CCL2
巨噬细胞
CCL20
胰腺癌
免疫/内分泌
发表日期：2024
文献求助 收藏

The regulation loop of MARVELD1 interacting with PARP1 in DNA damage response maintains genome stability and promotes therapy resistance of cancer cells

MARVELD1与PARP1在DNA损伤反应中的相互作用所形成的调控环路维持基因组稳定性，并促进癌细胞的治疗耐药性。

期刊:Cell Death and Differentiation
影响因子:15.4
doi:10.1038/s41418-023-01118-z
Sun, Haoxiu; Liu, Chao; Han, Fang; Lin, Xiaoyu; Cao, Liangyu; Liu, Chenxing; Ji, Qiuyu; Cui, Jinjin; Yao, Yuanfei; Wang, Bojun; Liao, Yuanyu; Nie, Huan; Zhang, Yanqiao; Li, Yu
肿瘤
PARP1
肿瘤免疫
信号转导
治疗耐药
PARP
细胞生物学
毒理研究
发表日期：2023
文献求助 收藏

Efficacy of Different Number of XELOX or SOX Chemotherapy Cycles After D2 Resection for Stage III Gastric Cancer

D2切除术后不同疗程数的XELOX或SOX化疗方案对III期胃癌疗效的影响

期刊:Journal of Gastric Cancer
影响因子:3.8
doi:10.5230/jgc.2022.22.e11
Yu, Yuanyuan; Zhang, Zicheng; Meng, Qianhao; Wang, Ke; Li, Qingwei; Ma, Yue; Yao, Yuanfei; Sun, Jie; Wang, Guangyu
胃癌
肿瘤
SOX
肿瘤免疫
LOX
发表日期：2022
文献求助 收藏

Corrigendum: ENC1 Facilitates Colorectal Carcinoma Tumorigenesis and Metastasis via JAK2/STAT5/AKT Axis-Mediated Epithelial Mesenchymal Transition and Stemness

更正：ENC1通过JAK2/STAT5/AKT轴介导的上皮间质转化和干性促进结直肠癌的肿瘤发生和转移

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2021.758671
Cui, Ying; Yang, Jiani; Bai, Yibing; Li, QingWei; Yao, Yuanfei; Liu, Chao; Wu, Feng; Zhang, Jingchun; Zhang, Yanqiao
肿瘤
肠癌
肿瘤免疫
JAK/STAT
JAK2
AKT
上皮间质转化
发表日期：2021
文献求助 收藏

Tumor-Derived Peptidoglycan Recognition Protein 2 Predicts Survival and Antitumor Immune Responses in Hepatocellular Carcinoma

肿瘤来源的肽聚糖识别蛋白2可预测肝细胞癌的生存率和抗肿瘤免疫反应

期刊:Hepatology
影响因子:15.8
doi:10.1002/hep.30924
Yang, Zongyi; Feng, Jia; Xiao, Li; Chen, Xi; Yao, Yuanfei; Li, Yiqun; Tang, Yu; Zhang, Shuai; Lu, Min; Qian, Yu; Wu, Hongjin; Shi, Ming
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2020
文献求助 收藏

Novel Metabolomics Serum Biomarkers for Pancreatic Ductal Adenocarcinoma by the Comparison of Pre-, Postoperative and Normal Samples

通过比较术前、术后和正常样本，鉴定胰腺导管腺癌的新型代谢组学血清生物标志物

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.41250
Zhang, Xiaohan; Shi, Xiuyun; Lu, Xin; Li, Yiqun; Zhan, Chao; Akhtar, Muhammad Luqman; Yang, Lijun; Bai, Yunfan; Zhao, Jianxiang; Wang, Yu; Yao, Yuanfei; Li, Yu; Nie, Huan
肿瘤
肿瘤免疫
代谢
发表日期：2020
文献求助 收藏

STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer

STAT1介导的FOXM1抑制作用增强胰腺癌对吉西他滨的敏感性

期刊:Clinical Science
影响因子:7.7
doi:10.1042/CS20180816
Liu, Chao; Shi, Jiaqi; Li, Qingwei; Li, Zhiwei; Lou, Changjie; Zhao, Qi; Zhu, Yuanyuan; Zhan, Fei; Lian, Jie; Wang, Bojun; Guan, Xin; Fang, Lin; Li, Zengxun; Wang, Yifei; Zhou, Bodong; Yao, Yuanfei; Zhang, Yanqiao
肿瘤
STAT1
肿瘤免疫
JAK/STAT
FOXM1
胰腺癌
发表日期：2019
文献求助 收藏

CSN6 expression is associated with pancreatic cancer progression and predicts poor prognosis

CSN6表达与胰腺癌进展相关，并预示着不良预后。

期刊:Cancer Biology & Therapy
影响因子:4.6
doi:10.1080/15384047.2019.1632143
Shi, Jiaqi; Guan, Xin; Zhan, Fei; Liu, Chao; Li, Zhiwei; Yao, Yuanfei; Wang, Bojun; Lou, Changjie; Zhang, Yanqiao
胰腺癌
肿瘤
肿瘤免疫
CSN6
发表日期：2019
文献求助 收藏